Nanotechnology News and Research

RSS

Researchers develop new technique for pH adjustments

How do individual cells or proteins react to changing pH levels? Researchers at the MESA+ Institute for Nanotechnology at the University of Twente have developed a technique for 'gently' adjusting pH: in other words, without damaging biomolecules. This should soon allow them to measure the activity of a single enzyme as a function of pH.

22 Dec 2009

UCLA CNSI and NOF collaborate in novel technologies for nanodelivery of drug therapies

The California NanoSystems Institute at UCLA has announced a new collaboration with Japan-based NOF Corp. to explore initiatives in nanotherapeutics research for new drug-delivery systems.

19 Dec 2009

Liquidia Technologies to receive $3 million in funding from NIST

Liquidia Technologies today announced it will receive approximately $3 million in funding from the U.S. Commerce Department’s National Institute of Standards and Technology (NIST) to further develop and scale-up the company’s PRINT manufacturing process.

18 Dec 2009

New technology sheds light on intracellular transport

Using new technology developed in his University of Oregon lab, chemist Andrew H. Marcus and his doctoral student Eric N. Senning have captured what they describe as well-orchestrated, actin-driven, mitochondrial movement within a single cell.

18 Dec 2009

Scientists report development of technology for changing the behavior of nanoparticles

In an advance that could help ease health and environmental concerns about the emerging nanotechnology industry, scientists are reporting development of technology for changing the behavior of nanoparticles in municipal sewage treatment plants - their main gateway into the environment.

17 Dec 2009

GSK and NanoBio sign license agreement for nanoemulsion technology

GlaxoSmithKline and Ann Arbor-based NanoBio Corporation announced today that they have signed an exclusive over-the-counter licensing agreement for NanoBio's unique nanoemulsion treatment for cold sores in the United States and Canada.

17 Dec 2009

Luna Innovations resolves litigation settlement with Hanson Medical

Luna Innovations Incorporated, a company focusing on sensing & instrumentation and nanotechnology, will hold a conference call with its investors relating to resolving the outstanding litigation with Hanson Medical. The settlement was announced in a press release on Friday, Dec. 11.

16 Dec 2009

Gamma Medica-Ideas signs exclusive license and commercialization agreement with Mayo Clinic

Gamma Medica-Ideas, Inc. ("GMI"), a leading developer of digital molecular imaging systems, announced today that it has signed an exclusive license and commercialization agreement with Mayo Clinic to further develop and commercialize a suite of technologies invented by a team of Mayo physicians and scientists, headed by Michael O'Connor, PhD.

15 Dec 2009

Rexahn Pharmaceuticals and TheraTarget sign joint research collaboration agreement

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, and TheraTarget, Inc., a developer of innovative polymer therapeutics for the treatment of cancer, today announced the formation of a joint research collaboration agreement.

15 Dec 2009

NPH acquires an exclusive license from UCLA for a suite of supramolecular nanoparticle technologies

NanoPacific Holdings, Inc. (NPH) announces the acquisition of an exclusive license from University of California at Los Angeles (UCLA) for a suite of supramolecular nanoparticle technologies. Under the terms of the agreement between NPH and UCLA, NPH will have an exclusive worldwide license of a system composed of a ternary mixture of modular components that self-assemble into supramolecular nanoparticles.

9 Dec 2009

New study focuses on chronic parental reactive negativity

Any parent knows that sometimes maintaining your cool with misbehaving children is a challenge. We all have times when we get frustrated or angry and lash out at someone without thinking. A new study by psychologists at Virginia Tech and two other universities suggests that parents with poorer working memory skills are less likely to be able to control their emotions with their children.

9 Dec 2009

Vestagen Technical Textiles introduces Nanotechnology-Based Healthcare Specialty Textiles

Vestagen Technical Textiles today announced its entry into the advanced performance textile arena with the introduction of the first of a new class of Nanotechnology-Based Healthcare Specialty Textiles.

9 Dec 2009

New IME-developed cardiac biomarker testing system saves time

Scientists at Singapore's Institute of Microelectronics (IME) have developed a rapid and sensitive integrated system to test simultaneously for specific cardiac biomarkers in finger prick amount of blood.

9 Dec 2009

Phase II clinical trial results of Doxorubicin Transdrug announced

BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announces positive survival data in its phase II clinical trial with doxorubicin Transdrug® in patients with advanced hepatocellular carcinoma (primary liver cancer).

9 Dec 2009

Licensing agreement to develop and commercialize potential treatment for Gaucher’s disease signed

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. represented Protalix (NYSE-Amex: PLX), a leading biopharmaceutical company, in its licensing agreement with Pfizer Inc. to develop and commercialize a potential treatment for Gaucher’s disease, a genetic disorder.

5 Dec 2009

ACAMP hosts health and medical seminar

Today ACAMP hosted a health & medical seminar, explaining how technologies like nanotechnology, biomaterials and microfluidics can play a powerful role in the creation of innovative healthcare products that help promote health and improve the quality, cost and outcomes of patient care, while opening new markets for Alberta companies worldwide.

4 Dec 2009

Silicon to transport drugs in the human body: a novel drug delivery method under development

Several Finnish universities have joined forces to develop an innovative drug delivery method that utilises silicon to transport drugs in the human body. Among other advances, the project has been able to sustain the effect of peptides controlling appetite, which may facilitate the use of nanotechnology for dieting purposes. The research is being carried out as part of the Academy of Finland's Research Programme on Nanoscience (FinNano).

4 Dec 2009

Specially developed PACEM system installed at Max Planck Institute for Biophysics

PACEM is a transmission electron microscope (TEM) designed to image low-contrast biological specimens. It was specially developed and installed at the Max Planck Institute for Biophysics (MPI-BP) by optical expert Carl Zeiss in Oberkochen and researchers from the Macromolecular Complexes excellence cluster in Frankfurt.

3 Dec 2009

MagForce Nanotechnologies applies for EU regulatory approval of its Nano-Cancer therapy

MagForce Nanotechnologies AG, the Berlin-based medical nanotechnology company majority owned by Nanostart AG, has submitted its application for the European regulatory approval of its Nano-Cancer® therapy.

2 Dec 2009

Georgia Institute of Technology receives contract to design nanostructures and cognition tools

The Georgia Institute of Technology has been awarded a U.S. Air Force Center of Excellence to design nanostructures for energy harvesting and adaptive materials, and to develop tools to optimize critical cognitive processes of the modern warfighter.

2 Dec 2009

Nanotechnology News and Research

Researchers develop new technique for pH adjustments

UCLA CNSI and NOF collaborate in novel technologies for nanodelivery of drug therapies

Liquidia Technologies to receive $3 million in funding from NIST

New technology sheds light on intracellular transport

Scientists report development of technology for changing the behavior of nanoparticles

GSK and NanoBio sign license agreement for nanoemulsion technology

Luna Innovations resolves litigation settlement with Hanson Medical

Gamma Medica-Ideas signs exclusive license and commercialization agreement with Mayo Clinic

Rexahn Pharmaceuticals and TheraTarget sign joint research collaboration agreement

NPH acquires an exclusive license from UCLA for a suite of supramolecular nanoparticle technologies

New study focuses on chronic parental reactive negativity

Vestagen Technical Textiles introduces Nanotechnology-Based Healthcare Specialty Textiles

New IME-developed cardiac biomarker testing system saves time

Phase II clinical trial results of Doxorubicin Transdrug announced

Licensing agreement to develop and commercialize potential treatment for Gaucher’s disease signed

ACAMP hosts health and medical seminar

Silicon to transport drugs in the human body: a novel drug delivery method under development

Specially developed PACEM system installed at Max Planck Institute for Biophysics

MagForce Nanotechnologies applies for EU regulatory approval of its Nano-Cancer therapy

Georgia Institute of Technology receives contract to design nanostructures and cognition tools

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News